Results 71 to 80 of about 3,491 (198)

Certolizumab Pegol Reduced Anterior Uveitis Flares Compared With Standard Non‐Biologic Treatment: Results From an Overlap Weighting Analysis in High‐Risk Patients With Axial Spondyloarthritis

open access: yesInternational Journal of Rheumatic Diseases, Volume 29, Issue 4, April 2026.
ABSTRACT Objective Acute anterior uveitis (AAU) is the most common extra‐musculoskeletal manifestation of axial spondyloarthritis (axSpA). This study compared the effect of the tumor necrosis factor inhibitor (TNFi) certolizumab pegol (CZP) with standard non‐biologic care, on AAU flare rate in patients with axSpA and high risk of recurrent uveitis ...
Nigil Haroon   +8 more
wiley   +1 more source

ASMD-FSMD Technique for Designing Digital Devices on FPGA

open access: yes, 2020
Recently, there has been, on the one hand, an increase in the complexity of digital device designs and, on the other hand, an increase in the requirements for the development time and the reliability of the designs. One of the directions of solving this problem is developing new techniques for designing digital devices.This paper proposes a new ...
openaire   +2 more sources

Acid sphingomyelinase deficiency in France: a retrospective survival study

open access: yesOrphanet Journal of Rare Diseases
Background Acid sphingomyelinase deficiency (ASMD) or Niemann–Pick disease types A, A/B, and B is a progressive, life-limiting, autosomal recessive disorder caused by sphingomyelin phosphodiesterase 1 (SMPD1) gene mutations.
Wladimir Mauhin   +17 more
doaj   +1 more source

Case Report of Gastrointestinal Bleeding in an Adult with Chronic Visceral Acid Sphingomyelinase Deficiency

open access: yesCase Reports in Gastrointestinal Medicine, 2019
Introduction. Acid sphingomyelinase deficiency (ASMD, also known as Niemann-Pick Type A and Type B disease) is a rare, inherited metabolic disorder.
David Cassiman   +3 more
doaj   +1 more source

Dynamic Borrowing With a Bias‐Tolerance Cap in Augmented Randomized Controlled Trials

open access: yesStatistics in Medicine, Volume 45, Issue 6-7, March 2026.
ABSTRACT Although randomized controlled trials (RCTs) are the gold standard for evaluating the efficacy and safety of treatments, they are challenged by cost, duration, enrollment, or ethical concerns. A possible solution is to incorporate external control data as a hybrid control group, for which various statistical methods are available.
Kota Sawada   +2 more
wiley   +1 more source

Construction of a prognostic assessment model for diabetic nephropathy based on serum fibrinogen and renal tissue IFTA score

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 3, Page 448-459, March 2026.
ABSTRACT Objective To explore the association between serum fibrinogen (FIB) and clinicopathological features and renal prognosis in type 2 diabetic nephropathy (T2DN), and develop a web‐based dynamic model to predict renal progression. Methods This paper retrospectively enrolled 173 biopsy‐proven T2DN patients and stratified them by the optimal FIB ...
Lin Ning   +5 more
wiley   +1 more source

Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency

open access: yesCell Death and Disease, 2023
Acid sphingomyelinase deficiency (ASMD) is a lysosomal storage disorder caused by mutations in the SMPD1 gene encoding for the acid sphingomyelinase (ASM). While intravenous infusion of recombinant ASM is an effective treatment for the peripheral disease,
Ángel Gaudioso   +4 more
doaj   +1 more source

Massive stars in sub-parsec rings around galactic centers

open access: yes, 2005
We consider the structure of self-gravitating marginally stable accretion disks in galactic centers in which a small fraction of the disk mass has been converted into proto-stars.
Nayakshin, Sergei
core   +3 more sources

Newborn Screening for Acid Sphingomyelinase Deficiency: Prevalence and Genotypic Findings in Italy

open access: yesInternational Journal of Neonatal Screening
Acid sphingomyelinase deficiency (ASMD) is a rare lysosomal storage disorder with a broad clinical spectrum. Early diagnosis and initiation of treatment are crucial for improving outcomes, yet the disease often goes undiagnosed due to its rarity and ...
Vincenza Gragnaniello   +7 more
doaj   +1 more source

A retrospective study of morbidity and mortality of chronic acid sphingomyelinase deficiency in Germany

open access: yesOrphanet Journal of Rare Diseases
Background Acid sphingomyelinase deficiency (ASMD) is a rare, progressive, potentially fatal lysosomal storage disease that exhibits a broad spectrum of clinical phenotypes.
Eugen Mengel   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy